Clinical Trial Update: Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating maintenance therapy with a combination of fluzoparib and famitinib after a first-line platinum response…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Famitinib (Famitinib)
• Fluzoparib (fluzoparib)

Snippet

Sponsor: Jinhua Zhou | Conditions: Ovarian Cancer | Phase 2 | Status: NOT_YET_RECRUITING